| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |